Drug

hepatitis B surface antigen vaccine

In clinical development

Emerging researchLate-stage developmentRising momentum

Also known as Antigen of Hepatitis B virus surface protein, Comvax, Engerix-B, HBSAG+17 more

Antigen of Hepatitis B virus surface protein, Comvax, Engerix-B, HBSAG, HEPATITIS B, HEPATITIS B SURFACE ANTIGEN, HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN, Hep B, unspecified formulation, Hepatitis B Vaccine, Hepatitis B surface antigens, Hepatitis B virus hbsag surface protein antigen, Hepatitis-B surface antigen, Heplisav-B, PEDIARIX, PreHevbrio, Recombivax, Twinrix, Vaxelis, hepatitis B vaccine, unspecified formulation, hepatitis B virus vaccine, Hepatitis B Surface Antigen (rDNA).

RxNorm797752

Research papers

Active clinical trials

Latest activity

beta

Recent clinical, regulatory, research and industry developments relating to this drug.

A Randomized, Open-Label, Multicenter Phase II Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Combination With Hepatitis B Vaccine or Pegylated Interferon α-2b (Peg-IFN) in Participants With HBeAg-Negative Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogue (NAs)

Clinical trial2026-05-20Results expected Q3 2027 · ClinicalTrials.gov

Prophylactic Vaccines as Therapy: Prevention of Recurrence of Extensive Genital Warts

Clinical trial2026-01-23Results posted · ClinicalTrials.gov

Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers Among Women of Childbearing Age, and Young Adults in Zimbabwe in the Context of Mental Health: a Multimodal, Multifaceted Approach.

Clinical trial2026-01-21Results expected Q3 2031 · ClinicalTrials.gov

HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers

Clinical trial2025-09-29Terminated · ClinicalTrials.gov

Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL)

Clinical trial2025-09-18Terminated · ClinicalTrials.gov

B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B

Clinical trial2025-07-20Results posted · ClinicalTrials.gov

Evaluation of the Efficacy of Cryotherapy Combined With Intralesional Hepatitis B Virus Vaccine Versus Either Therapy in the Treatment of Multiple Cutaneous Warts :a Comparative Study

Clinical trial2025-05-20Primary completion · ClinicalTrials.gov

An efficient vaccine clinical trial: ACTG A5379 hepatitis B vaccine trial in persons with HIV.

Research2025-03-26Vaccine

Optimal Timing of Hepatitis B Vaccination After Transplants: a Randomized Clinical Study

Clinical trial2025-03-21Results expected Q2 2028 · ClinicalTrials.gov

HepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse: The BEe-HIVe Randomized Clinical Trial.

Research2025-01-01JAMA

Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus.

Research2023-08-01Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Comparative immunogenicity under field conditions of two recombinant hepatitis B vaccines in 8-10-year-old children.

Research2000-02-01Vaccine

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name

hepatitis B surface antigen vaccine

Aliases & brands

Antigen of Hepatitis B virus surface proteinComvaxEngerix-BHBSAGHEPATITIS BHEPATITIS B SURFACE ANTIGENHEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGENHep B, unspecified formulationHepatitis B VaccineHepatitis B surface antigensHepatitis B virus hbsag surface protein antigenHepatitis-B surface antigenHeplisav-BPEDIARIXPreHevbrioRecombivaxTwinrixVaxelishepatitis B vaccine, unspecified formulationhepatitis B virus vaccineHepatitis B Surface Antigen (rDNA)

RxNorm CUI

797752